Chinese package insert for Mozobil (plerixafor) injection 1.2 ml:24 mg, covering indications, dosing, renal-impairment adjustments and adverse reactions.
This is the Chinese prescribing information (package insert) for Mozobil (释倍灵), plerixafor injection, supplied as 1.2 ml of a 20 mg/mL clear, colorless to pale-yellow solution. It is indicated for use with G-CSF to mobilize hematopoietic stem cells into the peripheral blood in patients with non-Hodgkin lymphoma (NHL) and multiple myeloma (MM) so that stem cells can be collected and used for autologous transplantation.
The document gives the recommended subcutaneous dose based on body weight (20 mg fixed dose or 0.24 mg/kg for patients ≤83 kg; 0.24 mg/kg for patients >83 kg, not exceeding 40 mg/day), dosing 11 hours before each collection for up to 4 consecutive days after 4 days of G-CSF, dose reduction in moderate to severe renal impairment, and notes on pediatric and elderly patients. It also lists adverse reactions from clinical trials and post-marketing reports, contraindications, and warnings including anaphylaxis, leukocytosis, thrombocytopenia, splenomegaly and spleen rupture. This manual is written in Chinese.
| Strength | 1.2 ml : 24 mg |
|---|---|
| Concentration | 20 mg/mL |
| Molecular formula | C28H54N8 |
| Molecular weight | 502.79 |
| Appearance | Clear, colorless to pale-yellow liquid |
| Recommended dose, body weight ≤83 kg | 20 mg fixed dose or 0.24 mg/kg |
| Maximum daily dose | 40 mg/day |
In combination with G-CSF, it is used to mobilize hematopoietic stem cells into the peripheral blood in patients with non-Hodgkin lymphoma and multiple myeloma, so the cells can be collected and used for autologous transplantation.
Patients weighing 83 kg or less receive a 20 mg fixed dose or 0.24 mg/kg; patients over 83 kg receive 0.24 mg/kg, and the dose must not exceed 40 mg per day.
In patients with estimated creatinine clearance ≤50 mL/min the dose is reduced by one third (13 mg or 0.16 mg/kg) and must not exceed 27 mg per day.
It is given 11 hours before each collection, for up to 4 consecutive days, after the patient has received G-CSF once daily for 4 days.